Morning Movers 02/24: (KCP) (AXTI) (NDSN) Higher; (KND) (RBCN) (DECK) Lower
Tweet
Share
E-mail
Get Alerts KCP Hot Sheet
Join SI Premium – FREE
Kenneth Cole Productions, Inc. (NYSE: KCP) 21.4% HIGHER; Kenneth D. Cole today announced that he has proposed to acquire through a merger transaction 100 percent of the outstanding publicly held shares of common stock of the company. Mr. Cole is Chairman and Chief Creative Officer of the Company and currently owns approximately 47% of the common stock (representing approximately 89% of the voting power) of the Company.
Kindred Healthcare, Inc. (NYSE: KND) 17.6% LOWER; reported Q4 EPS of $0.27, $0.09 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.58 billion. Kindred Healthcare, Inc. sees FY2012 EPS of $1.35-$1.55, versus prior guidance of $1.65-$1.85 and the consensus of $1.69. Kindred Healthcare, Inc. sees FY2012 revenue of $6.3 billion, versus the consensus of $6.4 billion.
Rubicon Technology, Inc. (NASDAQ: RBCN) 17.4% LOWER; reported Q4 EPS of $0.04, $0.03 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $19.4 million versus the consensus estimate of $20.16 million. Rubicon Technology, Inc. sees Q1 2012 EPS of $-0.10-$-0.14. Street looking for EPS of 11c.
AXT, Inc. (NASDAQ: AXTI) 14.5% HIGHER; reported Q4 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $21.2 million versus the consensus estimate of $21.34 million. Sees Q1 2012 EPS of $0.07-$0.11, versus the consensus of $0.08. Sees Q1 2012 revenue of $21-$24 million, versus the consensus of $20.54 million.
Nordson Corp (NASDAQ: NDSN) 14.2% HIGHER; reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $275.8 million versus the consensus estimate of $274.16 million. Sees Q2 2012 revenue of $313-$326 million, versus the consensus of $316.5 million.
Omnivision Technologies, Inc. (NASDAQ: OVTI) 12.1% HIGHER; reported Q3 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $185.2 million versus the consensus estimate of $175.47 million. Sees Q4 2012 EPS of $0.00-$0.13, versus the consensus of $0.10. Omnivision Technologies, Inc. sees Q4 2012 revenue of $195-$215 million, versus the consensus of $170.7 million.
Deckers Outdoor Corp (NASDAQ: DECK) 11.8% LOWER; reported Q4 EPS of $3.18, $0.04 better than the analyst estimate of $3.14. Revenue for the quarter came in at $603.9 million versus the consensus estimate of $565.21 million. Based upon current visibility, the Company expects full year revenues to increase approximately 15% over 2011 levels. Also announced a $100 million buyback.
Pacific Ethanol (Nasdaq: PEIX) 10.1% HIGHER; with crude oil continuing higher once again today (now over $108.50 per barrel), traders may be looking to play the rise with alt-energy type stocks. About 3.8 million shares have already traded hands today, compared to the stock's average daily volume of about 4.5 million shares.
Celldex (Nasdaq: CLDX) 9.4% LOWER; prices its public offering of 10.5 million common shares at $3.85 per share for net proceeds of $37,744,500. The company granted the underwriters a 30-day option to purchase up to an additional 1.575 million shares.
Merit Medical Systems, Inc. (NASDAQ: MMSI) 9% LOWER; reported Q4 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $91.1 million versus the consensus estimate of $91.86 million. The stock was downgraded at Stephens.
Kindred Healthcare, Inc. (NYSE: KND) 17.6% LOWER; reported Q4 EPS of $0.27, $0.09 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.58 billion. Kindred Healthcare, Inc. sees FY2012 EPS of $1.35-$1.55, versus prior guidance of $1.65-$1.85 and the consensus of $1.69. Kindred Healthcare, Inc. sees FY2012 revenue of $6.3 billion, versus the consensus of $6.4 billion.
Rubicon Technology, Inc. (NASDAQ: RBCN) 17.4% LOWER; reported Q4 EPS of $0.04, $0.03 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $19.4 million versus the consensus estimate of $20.16 million. Rubicon Technology, Inc. sees Q1 2012 EPS of $-0.10-$-0.14. Street looking for EPS of 11c.
AXT, Inc. (NASDAQ: AXTI) 14.5% HIGHER; reported Q4 EPS of $0.08, $0.01 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $21.2 million versus the consensus estimate of $21.34 million. Sees Q1 2012 EPS of $0.07-$0.11, versus the consensus of $0.08. Sees Q1 2012 revenue of $21-$24 million, versus the consensus of $20.54 million.
Nordson Corp (NASDAQ: NDSN) 14.2% HIGHER; reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $275.8 million versus the consensus estimate of $274.16 million. Sees Q2 2012 revenue of $313-$326 million, versus the consensus of $316.5 million.
Omnivision Technologies, Inc. (NASDAQ: OVTI) 12.1% HIGHER; reported Q3 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $185.2 million versus the consensus estimate of $175.47 million. Sees Q4 2012 EPS of $0.00-$0.13, versus the consensus of $0.10. Omnivision Technologies, Inc. sees Q4 2012 revenue of $195-$215 million, versus the consensus of $170.7 million.
Deckers Outdoor Corp (NASDAQ: DECK) 11.8% LOWER; reported Q4 EPS of $3.18, $0.04 better than the analyst estimate of $3.14. Revenue for the quarter came in at $603.9 million versus the consensus estimate of $565.21 million. Based upon current visibility, the Company expects full year revenues to increase approximately 15% over 2011 levels. Also announced a $100 million buyback.
Pacific Ethanol (Nasdaq: PEIX) 10.1% HIGHER; with crude oil continuing higher once again today (now over $108.50 per barrel), traders may be looking to play the rise with alt-energy type stocks. About 3.8 million shares have already traded hands today, compared to the stock's average daily volume of about 4.5 million shares.
Celldex (Nasdaq: CLDX) 9.4% LOWER; prices its public offering of 10.5 million common shares at $3.85 per share for net proceeds of $37,744,500. The company granted the underwriters a 30-day option to purchase up to an additional 1.575 million shares.
Merit Medical Systems, Inc. (NASDAQ: MMSI) 9% LOWER; reported Q4 EPS of $0.18, $0.01 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $91.1 million versus the consensus estimate of $91.86 million. The stock was downgraded at Stephens.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran’s president calls for end to war with US
- TEN Ltd. Announces Date for the Second Quarter and Six Months 2026 Results, Conference Call and Webcast
- Take Five: Six months of war
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Crude Oil, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
